http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114344260-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da87b56482160b96a1b516ccc5bd6a08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
filingDate | 2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ac48224f20a4d9d99587fb0a6d52af4 |
publicationDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-114344260-A |
titleOfInvention | A drug delivery system capable of crossing the blood-brain barrier |
abstract | The invention provides a drug carrier capable of passing through the blood-brain barrier, which is a nano-micelle formed by a positively charged multi-block polyurethane encapsulating drug, which can transport the drug through the blood-brain barrier. The invention also provides a drug-carrying system formed by the positively charged multi-block polyurethane encapsulating the drug, which can pass through the blood-brain barrier. The drug-carrying system capable of passing through the blood-brain barrier provided by the invention is stable and has a high drug-carrying capacity, can effectively pass through the blood-brain barrier to realize brain drug accumulation, has good biocompatibility, and has a good application prospect. |
priorityDate | 2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.